3 EU Chemical Stocks Gaining From The Shift Away From Chinese Imports

EU and China are locked in a trade rethink, with a daily goods gap of more than €1b and fresh talks circling cars, chemicals and rare earths. That kind of fault line can reshape where supply chains anchor and where profits accrue. This article walks through three EU listed chemical stocks that are directly exposed to this story and explains why their role as potential China substitutes deserves a closer look right now.

The stocks covered below are only a small sample of the opportunities created by this trade reset, and the full screen identified 11 more EU listed chemical players with equally compelling stories that are not included here.

To review that broader universe for yourself, go to the EU-Listed Chemical Producers and Distributors Substituting for Chinese Imports screener to identify, filter and analyze the highest conviction ideas in one place.

Aperam (ENXTAM:APAM)

Overview: Aperam produces stainless steel and specialty alloys, supplying EU and global manufacturers that want reliable alternatives to China sourced metal inputs.

Operations: Most revenue comes from Stainless & Electrical Steel at €3.8b, Services & Solutions at €2.0b, and Recycling & Renewables at €1.6b, with €1.1b from Alloys & Specialties.

Market Cap: €3.3b

Aperam matters for this screener because its EU based stainless and alloy output gives local industries a credible substitute for imported Chinese steel when trade rules push buyers toward regional suppliers.

"Aperam's leadership in recycled stainless and specialty alloys is positioned to benefit from global policies that support the shift to circular materials in autos, hydrogen, batteries, and green infrastructure, with potential implications for revenue and pricing dynamics."

What really moves the dial for Aperam is how one unresolved policy shift could reshape pricing power and long term margin potential.

If that policy shift is what you are watching, the full narrative for Aperam explains how pricing power, EU trade moves and circular metals demand could interact in the period ahead.

AlzChem Group (XTRA:ACT0)

Overview: AlzChem Group is a Germany based specialty chemicals producer supplying nutrition, agriculture, metallurgy, defense and renewable energy customers worldwide.

Operations: AlzChem Group generates about €398 million from Specialty Chemicals and €152 million from Basics & Intermediates, with smaller contributions from Other & Holding and segment adjustments.

Market Cap: €1.6b

AlzChem Group fits this EU reshoring theme because it manufactures high value chemical specialties inside Europe, giving local buyers a credible alternative to certain China sourced products at a moment when policy makers are rethinking trade exposure.

"Expanding human nutrition and dairy related creatine applications are increasing demand for Creapure and Creavitalis. This supports higher volumes in Specialty Chemicals and can lift group revenue and earnings if pricing remains resilient."

What happens to AlzChem Group’s margins if one quiet shift in customer pricing power breaks in its favor rather than against it?

If that pricing power shift is what you are tracking, the full narrative for AlzChem Group maps how volume momentum, input costs and customer mix could be quietly decoupling.

HEXPOL (OM:HPOL B)

Overview: HEXPOL develops and sells polymer compounds and engineered rubber products that help European manufacturers replace some China sourced material inputs.

Operations: HEXPOL Engineered Products contributes SEK 1,571 million of revenue, with reported segment adjustments of SEK 17,423 million affecting the overall group presentation.

Market Cap: SEK 32.8b

HEXPOL matters in this EU chemicals screen because its rubber compounds and engineered components give local manufacturers a ready substitute when sourcing shifts away from Chinese polymer suppliers.

"If Hexpol can continue to buy companies at 7 to 8x EBITDA while the market values Hexpol at 12 to 14x, value is created instantly through multiple arbitrage"

What happens to HEXPOL’s earnings power if one quiet change in customer demand for locally produced compounds tightens pricing more than expected.

If that shift in local pricing power is what you care about, the full narrative for HEXPOL illustrates how HEXPOL’s acquisition strategy and end market mix could be quietly accelerating.

Seeking Alternatives Before Others Catch On

Fresh ideas move first. Breakout themes can gain momentum while the data is still under the radar. Do not get caught reacting after prices start moving sharply; consider acting before the crowd.

• Target cash generative growth stories before they get crowded by screening for 178 high quality undervalued stocks that pair solid balance sheets with room for sentiment to improve.
• Spot income workhorses while yields remain elevated by scanning the 161 dividend fortresses that focus on durability and payout support.
• Track resilient operators built to handle shocks by reviewing the 229 resilient stocks with low risk scores that filter for stronger financial footing and steadier risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com